ResearchMoz

Browse reports in Therapeutic Area

Displaying 1 to 30 (of 893 records)
Peptide Therapeutics Pipeline Database: 1-Year Subscription
Nov 2014   |   By - La Merie Publishing
Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each project (file) is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of...
$1016
Europe Ambulatory Surgical & Emergency Center Services Market: (Pain Management, Ophthalmology, Gastrointestinal, Pulmonary, Dermatology, Vascular, Urology, ENT, Orthopedics, Obstetrics and General Surgery) - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
Nov 2014   |   By - Transparency Market Research
Ambulatory surgery is defined as the admission of patients for planned surgical procedures and discharge on the same day. Ambulatory surgical and emergency center service offers cost-effective and time saving approach to facilitate variety of ophthalmology, urology, gastrointestinal, orthopedic, vascular, pulmonary, pain management and other surgeries. Ambulatory surgical process is been...
$4795
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
Oct 2014   |   By - GBI Research
GBI Research, a leading business intelligence provider, has released its latest research report: “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts...
$4995
NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Oct 2014   |   By - Transparency Market Research
This study on novel drug delivery systems (NDDS) in cancer therapy comprises study of technologies such as embolization devices, liquid embolics and nanoparticles that offer unique approaches in cancer remedy. Several embolic agents are used by interventional radiologists for the selective occlusion of arteries supplying blood to tumors. The selection of an embolic agent depends on various...
$4795
United States - Pain Management Therapeutics Patients & Market Analysis
Oct 2014   |   By - Renub Research
United States – Pain Management Therapeutics Market, population and Pipeline Products Analysis Pain management is one of the fast growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The United States pain management therapeutics market has huge potential for growth due to the large population that is affected by...
$1100
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
Oct 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research, ‘Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries’, which provides insights into Major Depressive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany,...
$4995
Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth
Sep 2014   |   By - GBI Research
GBI Research, a leading business intelligence provider, has released its latest research report “Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth.” Melanoma is a highly heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM), Mucosal Melanoma (MM), melanoma of the internal organs, and,...
$4995
Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
Sep 2014   |   By - GBI Research
GBI Research, has released its latest pharma report - “Acute Myeloid Leukemia Therapeutics Market to 2020: Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts’. Treatment and prognosis in AML is strongly influenced by a patient’s age, and their cytogenetic profile. In the majority of cases these two prognostic influences are linked, with a higher...
$4995
Hospital Infection Therapeutics Market (Drug Type: Antibacterial, Antiviral and Antifungal Drugs; Infection Type: Hospital-Acquired Pneumonia, Urinary Tract Infections, Gastrointestinal Disorders, Bloodstream Infections, Surgical Site Infections and Other Hospital Infections) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Sep 2014   |   By - Transparency Market Research
This report on hospital infection therapeutics, studies the current as well as future prospects of the market globally. Hospital infections are also referred to as healthcare-associated infections (HCAIs), or nosocomial infections or hospital-acquired infection (HAIs). HAIs can be defined as those infections that occur in patients when they are admitted to a hospital or any other...
$4795
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting
Sep 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting ’, which provides in-depth insights into the indication. It gives an estimation of market size for 2013 along with forecasts until 2020 for the...
$4995
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
Aug 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: ‘Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM’, which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region,...
$3500
Trends in Therapeutic Partnering
Aug 2014   |   By - Current Partnering
The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2009 to mid 2014. The report provides a detailed understanding and analysis of the most popular therapeutic targets for partnering in the period 2009 to mid 2014. The majority of deals are discovery, preclinical...
$3995
Cancer Monoclonal Antibody Partnering Terms and Agreements
Aug 2014   |   By - Current Partnering
The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer...
$1995
Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders
Jul 2014   |   By - La Merie Publishing
This business report from July 2014 is based on the identification, description and assessment of all relevant stakeholders in the field of botulinum neurotoxins. The report analyzes the existing product portfolios in regulated and less regulated markets, commercial information, and measures to maintain sales and market shares by upside indications and life cycle management measures. The...
$2656
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
Jul 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an...
$3500
Global and China Progesterone Industry 2014 Deep Research Report
Jul 2014   |   By - QYResearch
The report provides a basic overview of the industry including definitions, applications and industry chain structure. Global market analysis and Chinese domestic market analysis are provided with a focus on history, developments, trends and competitive landscape of the market. A comparison between the international and Chinese situation is also offered. 2014 Deep Research Report on...
$2200
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany
Jun 2014   |   By - GBI Research
GBI Research, a leading business intelligence provider, has released its latest research report: “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany”. Due to the poor prognosis under currently available treatments, therapies with high potency are in strong demand in the...
$3500
Market Snapshot: Glucose Monitoring Devices 2014 - Benelux and Scandinavia
Jun 2014   |   By - GBI Research
GBI Research’s report: “Glucose Monitoring Devices 2014 – Benelux and Scandinavia” provides quantitative analysis of the two glucose monitoring devices market segments: blood glucose meters and blood glucose test strips. The analysis includes market size data by revenue and volume over the 2006–2020 period and key company share data by revenue and volume in...
$3500
Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries
Jun 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: ‘Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 – Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries ’, which provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five...
$3500
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs
Jun 2014   |   By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research: ‘Breast Cancer Therapeutics in Major Developed Markets to 2020 – Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs ’, which provides in-depth analysis of breast cancer therapeutics market within the eight major geographies of the US, Canada, the top...
$3500
Leukemia Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008...
$4000
Skin Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...
$4000
Colon Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Colon Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...
$4000
Brain Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...
$4000
Cervical Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data...
$4000
Kidney Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...
$4000
Liver Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...
$4000
Digestive Remedies Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Digestive Remedies has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and...
$4000
Respiratory Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and...
$4000
Lung Cancer Treatment Drugs Markets in China
Jun 2014   |   By - Asia Market Information & Development Company
China's demand for Lung Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...
$4000
 
Displaying 1 to 30 (of 893 records)

Therapeutic Area Market Research Reports & Industry Analysis

A Therapeutic area typically refers to a particular category of condition or disease that has known medical treatments, drugs, or other promising drug discoveries in development. It is a method of classifying medical drugs without any reference to the form or type of therapy, or without taking a look at the disease it treats. 

For instance, cardiology could be included in the therapeutic area. Similarly, other categories such as dermatology, urology, psychotherapy, travel medicine, gynecological therapy could be classified as therapeutic areas too.  

The global therapy industry includes treatments intended to protect, cure, or manage specific diseases or illnesses in the body. Nonetheless, the treatment of every therapeutic area and its subsequent conditions vary widely and independently. 

Representing Internet’s leading research reports from industry experts and analysts, ResearchMoz is your go-to-source of information for therapeutic areas. All our reports are put together by our efficient team of analysts that use data and information sourced from leading primary and secondary contacts, corporate websites, investor presentations, and industry-specific third party sources across various therapy areas. We are here to cater you with the right research reports to fulfill your requirements and purchase budgets. Find the information you need on therapeutic area of pharmaceutical and healthcare markets on ResearchMoz.us.  

Therapeutic Area

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData